StockData
Alzamend Neuro, Inc. logo

Alzamend Neuro, Inc. (ALZN) income statement

ALZNNasdaqPharmaceutical PreparationsFiscal year ends April 30
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 10, 2026Score 4/30
$0.78−0.24 (-23.94%)

Close on Nov 20, 2026Market cap $3.74MP/E –Yield –

Alzamend Neuro, Inc. income statement

Ratios

Latest available, balances at Jul 31, 2026

Profitability, FY

Gross margin
–
Operating margin
–
Net margin
–
Return on equity, FY2026
-373.2%

Financial strength

Current ratio
–
Debt to equity
–
Debt to assets
–
Cash to current liabilities
–

Valuation

P/E ratio
–
Price to sales
–
Price to book
0.65
Dividend yield
–

See a number that looks wrong?